This evolution is underscored by expanded service offerings and a continued commitment to safe and effective treatment protocols. The centre, founded by esteemed Professors Gideon Lack, Adam Fox, and George Du Toit, remains a pioneer in paediatric allergy care, championed by innovative treatments such as PALFORZIA, an FDA-approved therapy that has shifted the treatment paradigm from avoidance to active management of peanut allergies. This rebranding symbolises our ambition to provide comprehensive care that maintains the highest safety standards and caters responsively to the diverse needs of families and individuals with severe allergies. Revolutionising Allergy Treatment with PALFORZIA PALFORZIA's (peanut oral immunotherapy) approval in 2020, marking the first licensed food immunotherapy treatment in both the US and Europe, was a key driver for expansion of other OIT treatments.